Richard Pye has been appointed as chief financial officer and executive director at clinical AI technology company Sensyne Health.
He was previously Sensyne’s chief investment officer.
Michael Norris, Sensyne’s interim CFO, and Geoff Race, co-founder and CFO of Minerva Neurosciences, have joined the Sensyne board as non-executive directors.
Sir Bruce Keogh, chair of Sensyne Health, said: “I am delighted to welcome Richard, Geoff and Michael to the board of Sensyne. I would like to thank Michael for his excellent service as interim CFO and I am delighted he has agreed to stay with the business as a non-executive director. These senior appointments, combined with our strong team, will help us boost commercial momentum and accelerate the scaling of the business internationally.”
Related Posts
-
March 14, 2022
Keir is a former group managing director and CEO EMEA at HSBC, and is expected to chair Nationwide's board risk committee from July.
-
May 20, 2022
McErlain founded Square Mile Communications and holds non-executive director roles at Trackwise Designs and Dewhurst Group.
-
April 5, 2022
Dawes is solution centre director at the Net Zero Technology Centre, and will be a member of FirstGroup’s responsible business committee.
-
April 25, 2022
Patel is a senior vice-president at Procter & Gamble, and has held senior positions at Gillette, WH Smith and Coca-Cola.